AGP Executive Report
Last update: 10 hours agoDiabetes Care: Sun Pharma received South Africa approval to manufacture and market generic semaglutide, a once-weekly injection for adults with inadequately controlled type 2 diabetes, with launch planned soon. Court Watch: Delhi High Court heard a PIL seeking urgent medical treatment for climate activist Sonam Wangchuk on an indefinite hunger strike; the bench asked Centre and Delhi govt to respond and listed further hearing. Pediatric Breakthrough: AIIMS Delhi doctors performed a rare lung-preserving surgery on a 4-month-old with congenital lung malformation affecting both lungs, discharging the infant two days after the procedure. Healthcare Access via AI: AIIMS Delhi launched an AI-driven healthcare executive programme at IIT-Madras Pravartak, while Google’s I/O Connect updates highlighted AI models for leprosy and sexual & reproductive health using MedGemma. Public Health & Safety: Karnataka High Court pulled up police over failure to inspect medical equipment in an alleged unnatural death case involving Cloudnine Hospital. Monsoon Health: Experts warn families stockpile the wrong medicines during monsoon; guidelines suggest home kits should focus on ORS, paracetamol, thermometer and safe water. Transport Health: Central Railway revised rules after an AC failure on a crowded local train caused breathing issues for commuters, allowing deboarding at the next station. Medical Innovation Pipeline: A report says India-origin pharma patent families have surged four-fold over a decade, with an innovation pipeline now topping 1,095 programmes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.